Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9036951rdf:typepubmed:Citationlld:pubmed
pubmed-article:9036951lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:9036951lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:9036951lifeskim:mentionsumls-concept:C0034790lld:lifeskim
pubmed-article:9036951lifeskim:mentionsumls-concept:C0031437lld:lifeskim
pubmed-article:9036951lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9036951lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:9036951lifeskim:mentionsumls-concept:C0205100lld:lifeskim
pubmed-article:9036951lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:9036951lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:9036951pubmed:issue5lld:pubmed
pubmed-article:9036951pubmed:dateCreated1997-3-11lld:pubmed
pubmed-article:9036951pubmed:abstractTextA novel subset of peripheral T cells, peripheral NK T cells, is found to be a major population comprising 5% of splenic T and 40% of bone marrow T cells. The majority of peripheral NK T cells are characterized by the expression of an invariant TCR-alpha encoded by V alpha 14/J alpha 281 with a one nucleotide N region. Moreover, a specific reduction of V alpha 14+ NK T cells has been demonstrated to be tightly associated with various autoimmune diseases, indicating their decisive role in autoimmune disease development. In this study, we investigated the phenotypes of peripheral V alpha 14+ NK T cells and their TCR-beta repertoire. Peripheral V alpha 14+ NK T cells, comprise two populations, i.e., small and large sized cells, at an equal frequency, belonged to the CD4- CD8- fraction, and are heat stable antigen(bright), macrophage-1bright, B220bright, CD45RBdim, and Mel-14dim, but CD5-, distinct from thymic NK T cells. TCR-beta analysis clearly showed that peripheral V alpha 14+ NK T cells utilized two to three dominant invariant TCR-beta, such as V beta 8.2 D beta J beta 2.5/V beta 7 D beta J beta 2.1 in the spleen and liver, V beta 8.2 D beta J beta 2.5/V beta 8.3 D beta J beta 2.2/V beta 7 D beta J beta 2.6 in the bone marrow, and V beta 7 D beta J beta 2.1/V beta 3 D beta J beta 1.2 in intestinal intraepithelial lymphocytes. Judging from the unusual surface phenotypes, such as heat stable antigen, macrophage-1, B220, CD45RBdim, and Mel-14dim, which are known to be T cell activation markers, peripheral V alpha 14+ NK T cells may always be activated under physiologic conditions, resulting in the oligoclonal expansion of V alpha 14+ NK T cells with different invariant TCR-beta in different peripheral organs. The unique features of V alpha 14+ NK T cells are discussed.lld:pubmed
pubmed-article:9036951pubmed:languageenglld:pubmed
pubmed-article:9036951pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9036951pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9036951pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9036951pubmed:statusMEDLINElld:pubmed
pubmed-article:9036951pubmed:monthMarlld:pubmed
pubmed-article:9036951pubmed:issn0022-1767lld:pubmed
pubmed-article:9036951pubmed:authorpubmed-author:ItoTTlld:pubmed
pubmed-article:9036951pubmed:authorpubmed-author:MoriyaHHlld:pubmed
pubmed-article:9036951pubmed:authorpubmed-author:TaniguchiMMlld:pubmed
pubmed-article:9036951pubmed:authorpubmed-author:MasudaKKlld:pubmed
pubmed-article:9036951pubmed:authorpubmed-author:TokuhisaTTlld:pubmed
pubmed-article:9036951pubmed:authorpubmed-author:KoikeTTlld:pubmed
pubmed-article:9036951pubmed:authorpubmed-author:TsuchidaKKlld:pubmed
pubmed-article:9036951pubmed:authorpubmed-author:MakinoYYlld:pubmed
pubmed-article:9036951pubmed:authorpubmed-author:AmanoMMlld:pubmed
pubmed-article:9036951pubmed:authorpubmed-author:TakahamaYYlld:pubmed
pubmed-article:9036951pubmed:authorpubmed-author:CukDDlld:pubmed
pubmed-article:9036951pubmed:authorpubmed-author:KosekiHHlld:pubmed
pubmed-article:9036951pubmed:issnTypePrintlld:pubmed
pubmed-article:9036951pubmed:day1lld:pubmed
pubmed-article:9036951pubmed:volume158lld:pubmed
pubmed-article:9036951pubmed:ownerNLMlld:pubmed
pubmed-article:9036951pubmed:authorsCompleteYlld:pubmed
pubmed-article:9036951pubmed:pagination2076-82lld:pubmed
pubmed-article:9036951pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:meshHeadingpubmed-meshheading:9036951-...lld:pubmed
pubmed-article:9036951pubmed:year1997lld:pubmed
pubmed-article:9036951pubmed:articleTitlePhenotypes and invariant alpha beta TCR expression of peripheral V alpha 14+ NK T cells.lld:pubmed
pubmed-article:9036951pubmed:affiliationJapan Science and Technology Corporation (JST), School of Medicine, Chiba University, Japan.lld:pubmed
pubmed-article:9036951pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9036951pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9036951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9036951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9036951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9036951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9036951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9036951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9036951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9036951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9036951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9036951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9036951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9036951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9036951lld:pubmed